Chudi Obioma Ndubaku

USPTO Granted Patents = 30 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 8.8

ph-index = 9

Forward Citations = 292(Granted Patents)

Location History:

Thomastown, AU (2015)
San Francisco, CA (US) (2012 - 2017)
Oakland, CA (US) (2020 - 2021)
South San Francisco, CA (US) (2012 - 2023)

Company Filing History:

Walter and Eliza Hall Institute of Medical Research

patents

3 out of 168

F. Hoffmann-La Roche Ag

patents

4. 3 out of 8

Chinook Therapeutics, Inc.

Abbott Laboratories Corporation

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11643421 - Process for the preparation of tricyclic PI3K inhibitor compounds and methods for using the same for the treatment of cancer (2023-05-09),

2. 11098077 - Locked nucleic acid cyclic dinucleotide compounds and uses thereof (2021-08-24),

3. 10988478 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2021-04-27),

4. 10975114 - Bis 2'-5′-RR-(3′F-A)(3′F-A) cyclic dinucleotide compound and uses thereof (2021-04-13),

5. 10906930 - Compositions and methods for activating 'stimulator of interferon gene'-dependent signalling (2021-02-02),

6. 10906918 - Process for the preparation of tricyclic PI3K inhibitor compounds and methods for using the same for the treatment of cancer (2021-02-02),

7. 10738056 - Pyrazolopyrimidinone compounds and uses thereof (2020-08-11),

8. 9670228 - Benzoxazepin PI3K inhibitor compounds and methods of use (2017-06-06),

9. 9592235 - Aminoquinazoline and pyridopyrimidine derivatives (2017-03-14),

10. 9586956 - Isoquinoline and naphthyridine derivatives (2017-03-07),

11. 9573899 - USP7 inhibitor compounds and methods of use (2017-02-21),

12. 9546182 - Tricyclic PI3K inhibitor compounds and methods of use (2017-01-17),

13. 9546178 - Benzoxazepin PI3K inhibitor compounds and methods of use (2017-01-17),

14. 9382241 - Aminoquinazoline and pyridopyrimidine derivatives (2016-07-05),

15. 9198918 - Benzoxazepin PI3K inhibitor compounds and methods of use (2015-12-01),

Title: Chudi Obioma Ndubaku: Innovator in Pharmaceutical Patents

Introduction: Chudi Obioma Ndubaku is a distinguished inventor based in Oakland, CA, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio consisting of 30 patents, Ndubaku has been instrumental in advancing medical treatments, particularly in oncology and immunology.

Latest Patents: Among his latest patents, one notable invention is the "Process for the preparation of tricyclic PI3K inhibitor compounds and methods for using the same for the treatment of cancer." This innovation provides methods that ensure high yield and purity of tricyclic PI3K inhibitor compounds in aqueous solvent systems, offering new avenues for cancer treatment. Another significant patent is centered around "Locked nucleic acid cyclic dinucleotide compounds and uses thereof." This invention introduces highly active locked nucleic acid cyclic-dinucleotide (LNA-CDN) immune stimulators that effectively activate dendritic cells via the STING receptor, promoting human STING-dependent type I interferon production.

Career Highlights: Chudi Obioma Ndubaku has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His tenure at these organizations has allowed him to refine his skills in drug development and patent innovation, contributing significantly to their research and development endeavors.

Collaborations: Throughout his career, Ndubaku has had the opportunity to collaborate with notable professionals in the field, including Danette Dudley and Alan G. Olivero. These partnerships have fostered a collaborative environment for innovation, enhancing the quality and impact of their collective work.

Conclusion: Chudi Obioma Ndubaku's contributions to pharmaceutical patents underscore his status as a leading figure in innovation. His recent patents reflect not only his expertise but also his commitment to advancing healthcare solutions. As a dedicated inventor, Ndubaku continues to inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.